Pharmaceutical Drug Delivery Market in the US – Size, Forecast, and Competitive Landscape: Explore NeOnc Technologies’ US Potential

Market Outlook: Pharmaceutical Drug Delivery Market in the US 2025-2029

The pharmaceutical drug delivery market in the US is rapidly evolving with innovations in technologies aimed at improving the efficacy, targeting, and patient compliance of drug therapies, including novel systems such as nanoparticles, controlled release mechanisms, and biologics delivery platforms. The market is expected to grow at a CAGR of 5%-7% between 2025 and 2029. Exact values for this market can be accessed upon purchasing the report. Key companies in this market include:

• Johnson & Johnson
• Baxter International
• Aptar Pharma
• Halozyme Therapeutics
• Ferring Pharmaceuticals
• Others

IPO Company Overview: NeOnc Technologies in the US pharmaceutical drug delivery market

NeOnc Technologies Holdings, Inc. has filed for an IPO with the US Securities and Exchange Commission in January 2025 under the ticker symbol NTHI, creating a new opportunity for investors. NeOnc Technologies is a biotechnology company focused on developing innovative drug delivery systems that aim to revolutionize the treatment of cancer and other complex diseases. By leveraging cutting-edge technologies, NeOnc is dedicated to improving the efficacy, targeting, and precision of therapies, ensuring better therapeutic outcomes while minimizing side effects.

Market Segmentation: How is the US pharmaceutical drug delivery market segmented?

Type

• Oral Drug Delivery
• Injectable Drug Delivery
• Transdermal Drug Delivery
• Pulmonary Drug Delivery
• Implantable Drug Delivery
• Nasal Drug Delivery

Application

• Oncology
• Cardiovascular
• Neurology
• Infectious Diseases
• Diabetes
• Pain Management

Oral drug delivery is the leading delivery type, driven by its ease of administration, patient preference, and cost-effectiveness. Oral tablets and capsules remain the most common form of drug delivery due to their convenience and wide acceptance in both chronic and acute conditions. Oncology leads in terms of applications, as drug delivery systems are crucial in improving the targeting, release, and efficacy of cancer therapies. With the rising prevalence of cancer and advancements in targeted therapies, specialized drug delivery systems help increase the effectiveness of treatments while minimizing side effects.

Investment Opportunities: Why explore the US pharmaceutical drug delivery market with Technavio?

Recent developments in the US pharmaceutical drug delivery market highlight significant advancements in both technologies and the approaches to enhancing drug efficacy and patient compliance. Innovations in nanotechnology and biologics have opened new possibilities for targeted drug delivery systems, allowing for the more efficient transportation of drugs to specific sites in the body, thus minimizing side effects and maximizing therapeutic benefits.

Technologies like nanoparticles, liposomes, and microneedles have shown promise in improving bioavailability and enabling the delivery of drugs that were previously difficult to administer, such as large molecules, proteins, and gene therapies. Moreover, controlled release and long-acting injectables have become increasingly prevalent, allowing patients to benefit from extended treatment regimens and improved compliance, particularly in chronic disease management.

The market has also seen a rise in personalized medicine and smart delivery systems, which aim to adapt drug delivery based on individual patient profiles and real-time data. Biodegradable drug delivery systems and implantable devices have emerged as solutions to reduce the need for frequent administrations, improving patient convenience and reducing healthcare costs. Regulatory support from the US FDA, which has streamlined approval processes for novel drug delivery technologies, has further accelerated innovation in the field. Partnerships between pharmaceutical companies, biotechnology firms, and medical device manufacturers are helping to drive the development of advanced delivery mechanisms, making drug delivery more precise, efficient, and patient-friendly.

Market Dynamics: What factors are influencing the pharmaceutical drug delivery market in the US?

Drivers

The pharmaceutical drug delivery market in the U.S. is primarily driven by the increasing demand for more efficient, targeted, and patient-friendly therapies. Advances in biotechnology, particularly nanotechnology and biologics, enable more precise drug delivery, reducing side effects and enhancing the effectiveness of treatments. Additionally, the rising prevalence of chronic diseases such as cancer, diabetes, and cardiovascular conditions has fueled demand for innovative drug delivery systems that improve patient compliance and convenience. Regulatory support from the FDA, which facilitates the approval of novel delivery methods, along with an increasing focus on personalized medicine, also contributes to the growth of this market.

Trends

Key trends in the pharmaceutical drug delivery market include the growing adoption of long-acting injectables and controlled release systems, which provide patients with extended therapeutic benefits and reduce the need for frequent dosing. Smart drug delivery systems and biodegradable carriers are gaining traction, offering improved targeting and reduced environmental impact. The rise of microneedles, transdermal patches, and implantable devices represents a shift toward non-invasive delivery methods that enhance patient compliance. Additionally, personalized medicine is influencing the development of customized drug delivery systems tailored to individual patient needs, driven by advancements in genetic and molecular profiling.

Opportunities

The pharmaceutical drug delivery market offers numerous growth opportunities, particularly in the development of novel drug delivery technologies that can enhance the bioavailability of difficult-to-deliver drugs such as biologics, peptides, and gene therapies. Emerging therapies in oncology and rare diseases present opportunities for new delivery systems that can target specific tissues and cells, reducing systemic side effects. The increasing trend toward home healthcare and self-administration devices also presents an opportunity for the development of user-friendly drug delivery systems. Furthermore, the growing demand for personalized drug delivery systems based on genetic and molecular data offers a promising avenue for pharmaceutical companies to create more effective treatments tailored to individual patient profiles.

Challenges

Despite the promising growth of the pharmaceutical drug delivery market, several challenges remain. One significant hurdle is the high cost of development and manufacturing, as creating advanced drug delivery systems often requires extensive research and specialized technology. Regulatory approval processes for new delivery methods can be lengthy and complex, adding to the time and cost of bringing innovations to market. Additionally, there are concerns related to patient adoption of new delivery systems, particularly those that require self-administration or the use of more complex devices. Ensuring that these systems are accessible, affordable, and meet the needs of diverse patient populations is crucial for the widespread adoption of new drug delivery technologies.

Investment Questions: Topics to consider when investing in the pharmaceutical drug delivery market in the US

How large is the target market for the drug delivery system?
Consider what the potential market size for the specific drug delivery technology is, and how many patients will benefit from it. The market needs to be large enough to justify the investment, considering the development and manufacturing costs.

What is the competition landscape?
The company’s product needs to differentiate itself from others in the market. It is important to understand whether there is a significant risk of market saturation or the emergence of alternative technologies.

What is the company’s financial health and funding strategy?
The company needs to have sufficient financial resources to fund research, development, and commercialization efforts for the drug delivery system, as well as a strategy for securing additional funding or partnerships to advance its product if necessary.

What is the timeline for product development and commercialization?
Consider the expected timeline for the development, clinical testing, and commercialization of the drug delivery system and whether there are any potential delays or risks that could hinder progress, such as regulatory hurdles or technical challenges.

What is the intellectual property strategy?
Understand whether the company has strong intellectual property protection for its drug delivery technologies, including patents and exclusive rights, as well as how likely it is that competitors could replicate or infringe on the technology.

What are the pricing and reimbursement strategies?
Know the expected pricing for the drug delivery system, and how it will be positioned in the healthcare market. What are the reimbursement prospects, and how will insurance companies and healthcare providers respond to the new delivery system?

For a detailed analysis of the pharmaceutical drug delivery market in the US, buy the full report

Technavio Report Insights: How Can Technavio Reports Help Investors Make Better Business Decisions?

Key Features of a Technavio Report: 

• Comprehensive Market Analysis: Provides a detailed overview of the pharmaceutical drug delivery market in the US, including market size, growth rate, segmentation, and regional analysis. 

• In-Depth

  Competitive Landscape:

  Offers insights into the competitive dynamics, market share and positioning, and product offerings of key players. 

• Future Market Trends: Identifies emerging trends and opportunities that can shape the future of the market. 

• Detailed Segmentation: Breaks down the market into various segments to help investors identify specific niches and target markets. 

• Expert Analysis: Provides expert insights and forecasts from industry analysts

FAQ

1. What are the key trends in the pharmaceutical drug delivery market?
Key trends in the market include the growing use of long-acting injectables, smart drug delivery systems, biodegradable drug carriers, and personalized medicine. Advances in nanotechnology and the development of biologics are driving innovations in targeted delivery and improving the bioavailability of drugs, particularly for difficult-to-deliver therapies like proteins, peptides, and gene-based treatments.

2. What are the benefits of controlled release drug delivery systems?
Controlled release drug delivery systems release medications over an extended period, ensuring consistent therapeutic levels in the body. This improves treatment outcomes by maintaining steady drug concentrations, reducing the frequency of dosing, and minimizing side effects compared to immediate-release forms. It also enhances patient compliance by simplifying drug regimens.

3. What challenges does the pharmaceutical drug delivery market face?
Challenges include high development and manufacturing costs, regulatory complexities, and market competition from existing therapies. Additionally, ensuring widespread patient adoption and addressing potential supply chain issues for advanced drug delivery devices can hinder growth. There is also the need for better reimbursement strategies for newer delivery methods and ensuring their accessibility to diverse patient populations.

4. How are regulatory agencies involved in the pharmaceutical drug delivery market?
Regulatory agencies like the U.S. Food and Drug Administration (FDA) play a critical role in approving new drug delivery technologies. The FDA evaluates the safety, efficacy, and quality of delivery systems through clinical trials and other assessments. Drug delivery technologies may also benefit from expedited approval processes and Orphan Drug Designation if they target rare or serious conditions.

5. What is personalized drug delivery, and why is it important?
Personalized drug delivery refers to the tailoring of treatment regimens and delivery systems based on individual patient characteristics, such as genetic makeup, disease profile, and lifestyle factors. This approach is important because it allows for more effective treatments by optimizing the drug type, dosage, and delivery method for each patient, reducing side effects, and improving outcomes.

6. What are the growth opportunities in the pharmaceutical drug delivery market?
Growth opportunities in the market lie in developing advanced drug delivery platforms for biologics, nanoparticles for targeted therapy, and patient-friendly systems that allow for self-administration of complex drugs. The increasing focus on chronic disease management, the rise of gene and cell therapies, and the growing demand for non-invasive delivery methods present substantial growth avenues.

Table of Contents

1 Executive Summary

• 1.1 Market overview
  • Executive Summary - Chart on Market Overview
  • Executive Summary - Data Table on Market Overview
  • Executive Summary - Chart on Global Market Characteristics
  • Executive Summary - Chart on Market by Geography
  • Executive Summary - Chart on Market Segmentation
  • Executive Summary - Chart on Incremental Growth
  • Executive Summary - Data Table on Incremental Growth
  • Executive Summary - Chart on Company Market Positioning

2 Technavio Analysis

• 2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
  • Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

• 2.2 Criticality of inputs and factors of differentiation
  • Overview on criticality of inputs and factors of differentiation

• 2.3 Factors of disruption
  • Overview on factors of disruption

• 2.4 Impact of drivers and challenges
  • Impact of drivers and challenges in 2024 and 2029

3 Market Landscape

• 3.1 Market ecosystem
  • Parent Market
  • Data Table on - Parent Market

• 3.2 Market characteristics
  • Market characteristics analysis

• 3.3 Value chain analysis
  • Value chain analysis

4 Market Sizing

• 4.1 Market definition
  • Offerings of companies included in the market definition

• 4.2 Market segment analysis
  • Market segments

• 4.3 Market size 2024

• 4.4 Market outlook: Forecast for 2024-2029
  • Chart on Global Market - Market size and forecast 2024-2029 ($ billion)
  • Data Table on Global Market - Market size and forecast 2024-2029 ($ billion)
  • Chart on Global Market: Year-over-year growth 2024-2029 (%)
  • Data Table on Global Market: Year-over-year growth 2024-2029 (%)

5 Historic Market Size

• 5.1 Global Market 2019 - 2023
  • Historic Market Size - Data Table on Global Market 2019 - 2023 ($ billion)

• 5.2 Segment Analysis 2019 - 2023
  • Historic Market Size – Segment Analysis 2019 - 2023 ($ billion)

• 5.4 Geography segment analysis 2019 - 2023
  • Historic Market Size - Geography Segment 2019 - 2023 ($ billion)

6 Qualitative Analysis

• 6.1 Impact of AI on the Global Market

7 Five Forces Analysis

• 7.1 Five forces summary
  • Five forces analysis - Comparison between 2024 and 2029

• 7.2 Bargaining power of buyers
  • Bargaining power of buyers - Impact of key factors 2024 and 2029

• 7.3 Bargaining power of suppliers
  • Bargaining power of suppliers - Impact of key factors in 2024 and 2029

• 7.4 Threat of new entrants
  • Threat of new entrants - Impact of key factors in 2024 and 2029

• 7.5 Threat of substitutes
  • Threat of substitutes - Impact of key factors in 2024 and 2029

• 7.6 Threat of rivalry
  • Threat of rivalry - Impact of key factors in 2024 and 2029

• 7.7 Market condition
  • Chart on market condition - Five forces 2024 and 2029

8 Market Segmentation

• 8.1 Market segments
  • Chart on Segmentation - Market share 2024-2029 (%)
  • Data Table on Segmentation - Market share 2024-2029 (%)

• 8.2 Segment Comparison
  • Chart on Comparison
  • Data Table on Comparison

• 8.3 Segment Market Opportunity
  • Market opportunity ($ billion)
  • Data Table on Market Opportunity ($ billion)

9 Customer Landscape

• 9.1 Customer landscape overview
  • Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

10 Geographic Landscape

• 10.1 Geographic segmentation
  • Chart on market share by geography 2024-2029 (%)
  • Data Table on market share by geography 2024-2029 (%)

• 10.2 Geographic comparison
  • Chart on Geographic comparison
  • Data Table on Geographic comparison

• 10.3 Market opportunity by geography
  • Market opportunity by geography ($ billion)
  • Data Tables on Market opportunity by geography ($ billion)

11 Drivers, Challenges, and Opportunity/Restraints

• 11.1 Market drivers

• 11.2 Market challenges

• 11.3 Impact of drivers and challenges
  • Impact of drivers and challenges in 2024 and 2029

• 11.4 Market opportunities/restraints

12 Competitive Landscape

• 12.1 Overview

• 12.2 Competitive Landscape
  • Overview on criticality of inputs and factors of differentiation

• 12.3 Landscape disruption
  • Overview on factors of disruption

• 12.4 Industry risks
  • Impact of key risks on business

13 Competitive Analysis

• 13.1 Companies profiled
  • Companies covered

• 13.2 Company ranking index
  • Company ranking index

• 13.3 Market positioning of companies
  • Matrix on companies position and classification

14 Appendix

• 14.1 Scope of the report

• 14.2 Inclusions and exclusions checklist
  • Inclusions checklist
  • Exclusions checklist

• 14.3 Currency conversion rates for US$
  • Currency conversion rates for US$

• 14.4 Research methodology
  • Research methodology

• 14.5 Data procurement
  • Information sources

• 14.6 Data validation
  • Data validation

• 14.7 Validation techniques employed for market sizing
  • Validation techniques employed for market sizing

• 14.8 Data synthesis
  • Data synthesis

• 14.9 360 degree market analysis
  • 360 degree market analysis

• 14.10 List of abbreviations
  • List of abbreviations